Merrimack Pharma Has Returned 21.8% Since SmarTrend Recommendation (MACK)
April 25, 2018 at 13:41 PM EDT
SmarTrend identified a Downtrend for Merrimack Pharma (NASDAQ:MACK) on December 6th, 2017 at $10.55. In approximately 5 months, Merrimack Pharma has returned 21.80% as of today's recent price of...